| Ticker |
APDN
|
| CIK | 0000744452 |
| SIC | 8734 |
| Sector | Services |
| Industry Category | Business Services |
| Industry Group | Services – Research, Development, Testing Labs |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. HaywardPresident and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, ... Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-AugustSTONY BROOK, NY / ACCESS Newswire / June 16, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning ... Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17STONY BROOK, NY / ACCESS Newswire / May 29, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update ... Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025STONY BROOK, NY / ACCESS Newswire / May 29, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-15 reverse stock split of its issued and ... Applied DNA Sciences Second Quarter 2025 Earnings: Misses ExpectationsApplied DNA Sciences ( NASDAQ:APDN ) Second Quarter 2025 Results Key Financial Results Net income: US$20.6m (up from... |
